GENEVA, July 3 -- RECODE THERAPEUTICS, INC. (1140 O'Brien DriveMenlo Park, California 94025), THE BOARD OF THE REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (210 West 7th StreetAustin, Texas 78701), SIEGWART, Daniel J. (c/o UT Southwestern Medical Center5323 Harry Hines Blvd.Dallas, Texas 75390), CHATTERJEE, Sumanta (c/o The Board of the Regents of The University of Texas System210 West 7th StreetAustin, Texas 78701), SUN, Yehui (c/o The Board of the Regents of The University of Texas System210 West 7th StreetAustin, Texas 78701), MOHAPATRA, Sakya (c/o ReCode Therapeutics, Inc.1140 O'Brien DriveMenlo Park, California 94025) filed a patent application (PCT/US2024/061579) for "GENE EDITING METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS" on...